CHIP dysfunction has also been reported in SBMA (and in amyotrophic lateral sclerosis [ALS]) and its overexpression has a beneficial effect in both diseases (Morishima et al., 2008). This evidence concerns the gene AR and amyotrophic lateral sclerosis.